Pelvic Parameters in Males With and Without Ankle Instability (NCT07594210) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Pelvic Parameters in Males With and Without Ankle Instability
38 participantsStarted 2026-05-07
Plain-language summary
This study aims to investigate the relationship between pelvic alignment and ankle stability in male athletes with and without a history of ankle sprain.
Chronic ankle instability is a common condition that may affect not only the ankle joint but also the alignment and function of other body segments, including the pelvis. Understanding this relationship may help improve injury prevention and rehabilitation strategies.
Participants will undergo clinical assessments, functional tests, and radiographic evaluation of pelvic parameters to compare findings between injured and non-injured groups.
The objective of this study is to determine whether differences in pelvic sagittal parameters are associated with ankle instability in male athletes.
Who can participate
Age range
18 Years – 35 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male football players aged between 18 and 35 years (Herzog et al., 2019; Jiang et al., 2022).
* A documented history of lateral ankle sprain (LAS) for at least 12 months before the study, with the initial injury resulting in a minimum of one day of weight-bearing restriction.
* Self-reported episodes of ankle "giving way" occurring at least twice within the 6-12 months preceding enrollment.
* The most recent injury must have occurred more than 3 months before study enrollment.
* A perceived sense of the injured ankle being chronically weaker and/or less functional than the contralateral side before the first LAS episode.
* A Cumberland Ankle Instability Tool (CAIT) score of less than 24 indicates chronic ankle instability.
* For group B: participants with no previous history of ankle sprain.
Exclusion Criteria:
* Bilateral LAS (Tahoon et al., 2022).
* Previous injury, fracture, or surgical intervention involving the spine, pelvis, or lower extremity.
* History of low back pain requiring medical or surgical intervention.
* Engagement in supervised or unsupervised ankle rehabilitation within one month before the study.
* Any LAS occurring within three months before participation.
* Leg length discrepancy exceeding 0.5 cm.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.